390 related articles for article (PubMed ID: 21585245)
21. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease.
Lew W; Chang JY; Jung JY; Bang D
Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865
[TBL] [Abstract][Full Text] [Related]
22. Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis.
Guan Q; Ma Y; Hillman CL; Ma A; Zhou G; Qing G; Peng Z
Vaccine; 2009 Nov; 27(50):7096-104. PubMed ID: 19786142
[TBL] [Abstract][Full Text] [Related]
23. Granulocyte colony-stimulating-factor-induced psoriasiform dermatitis resembles psoriasis with regard to abnormal cytokine expression and epidermal activation.
Mössner R; Beckmann I; Hallermann C; Neumann C; Reich K
Exp Dermatol; 2004 Jun; 13(6):340-6. PubMed ID: 15186319
[TBL] [Abstract][Full Text] [Related]
24. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells.
Hoeve MA; Savage ND; de Boer T; Langenberg DM; de Waal Malefyt R; Ottenhoff TH; Verreck FA
Eur J Immunol; 2006 Mar; 36(3):661-70. PubMed ID: 16482511
[TBL] [Abstract][Full Text] [Related]
25. Monocyte derived interleukin (IL)-23 is an important determinant of synovial IL-17A expression in rheumatoid arthritis.
Stamp LK; Easson A; Pettersson L; Highton J; Hessian PA
J Rheumatol; 2009 Nov; 36(11):2403-8. PubMed ID: 19797506
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-23: immunological roles and clinical implications.
Tan ZY; Bealgey KW; Fang Y; Gong YM; Bao S
Int J Biochem Cell Biol; 2009 Apr; 41(4):733-5. PubMed ID: 18725317
[TBL] [Abstract][Full Text] [Related]
27. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
28. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.
Lee E; Trepicchio WL; Oestreicher JL; Pittman D; Wang F; Chamian F; Dhodapkar M; Krueger JG
J Exp Med; 2004 Jan; 199(1):125-30. PubMed ID: 14707118
[TBL] [Abstract][Full Text] [Related]
30. New mediators of immunity and inflammation in inflammatory bowel disease.
Monteleone G; Fina D; Caruso R; Pallone F
Curr Opin Gastroenterol; 2006 Jul; 22(4):361-4. PubMed ID: 16760750
[TBL] [Abstract][Full Text] [Related]
31. Food-derived bioactives as potential regulators of the IL-12/IL-23 pathway implicated in inflammatory bowel diseases.
Danesi F; Philpott M; Huebner C; Bordoni A; Ferguson LR
Mutat Res; 2010 Aug; 690(1-2):139-44. PubMed ID: 20067801
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
33. ERK-MAP-kinases differentially regulate expression of IL-23 p19 compared with p40 and IFN-beta in Theiler's virus-infected RAW264.7 cells.
Petro TM
Immunol Lett; 2005 Feb; 97(1):47-53. PubMed ID: 15626475
[TBL] [Abstract][Full Text] [Related]
34. Astrocytes as antigen-presenting cells: expression of IL-12/IL-23.
Constantinescu CS; Tani M; Ransohoff RM; Wysocka M; Hilliard B; Fujioka T; Murphy S; Tighe PJ; Das Sarma J; Trinchieri G; Rostami A
J Neurochem; 2005 Oct; 95(2):331-40. PubMed ID: 16086689
[TBL] [Abstract][Full Text] [Related]
35. Synergism between tumor necrosis factor alpha and interleukin-17 to induce IL-23 p19 expression in fibroblast-like synoviocytes.
Goldberg M; Nadiv O; Luknar-Gabor N; Agar G; Beer Y; Katz Y
Mol Immunol; 2009 May; 46(8-9):1854-9. PubMed ID: 19201028
[TBL] [Abstract][Full Text] [Related]
36. Systemic photochemotherapy decreases the expression of IFN-γ, IL-12p40 and IL-23p19 in psoriatic plaques.
Ravić-Nikolić A; Radosavljević G; Jovanović I; Zdravković N; Mitrović S; Pavlović S; Arsenijević N
Eur J Dermatol; 2011; 21(1):53-7. PubMed ID: 21227895
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E2 exacerbates collagen-induced arthritis in mice through the inflammatory interleukin-23/interleukin-17 axis.
Sheibanie AF; Khayrullina T; Safadi FF; Ganea D
Arthritis Rheum; 2007 Aug; 56(8):2608-19. PubMed ID: 17665454
[TBL] [Abstract][Full Text] [Related]
38. Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency.
Mannon PJ; Fuss IJ; Dill S; Friend J; Groden C; Hornung R; Yang Z; Yi C; Quezado M; Brown M; Strober W
Gastroenterology; 2006 Sep; 131(3):748-56. PubMed ID: 16952544
[TBL] [Abstract][Full Text] [Related]
39. Expression and regulation of interleukin-23 subunits in human peripheral blood mononuclear cells and hematopoietic cell lines in response to various inducers.
Ma XT; Zhang XJ; Zhang B; Geng YQ; Lin YM; Li G; Wu KF
Cell Biol Int; 2004; 28(10):689-97. PubMed ID: 15516327
[TBL] [Abstract][Full Text] [Related]
40. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.
Becker C; Wirtz S; Blessing M; Pirhonen J; Strand D; Bechthold O; Frick J; Galle PR; Autenrieth I; Neurath MF
J Clin Invest; 2003 Sep; 112(5):693-706. PubMed ID: 12952918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
